WeVote
Log In

Bill

Bill

HSB 224

A bill for an act relating to the licensure of medical cannabidiol dispensaries.

2025-2026 Regular Session

Iowa bill establishes licensing requirements for medical cannabidiol dispensaries, advancing with unanimous committee approval toward regulated patient access.

Committee report approving bill, renumbered as HF 990.
#drugs #marijuana
0
WeVote Research Nonpartisan
Bill Summary · HSB 224

Legislative bill overview

HSB 224 establishes a licensing framework for medical cannabidiol (CBD) dispensaries in Iowa. The bill has advanced through committee review with unanimous support and is now renumbered as HF 990, indicating it has progressed to later legislative stages.

Why is this important

This legislation addresses the regulatory gap around CBD product distribution in Iowa, a state where medical cannabis remains largely restricted. The bill's passage would create legal pathways for patients to access cannabidiol products through licensed dispensaries rather than unregulated channels, while generating state oversight and tax revenue.

Potential points of contention

  • Definition and scope of cannabidiol products: The bill's specific parameters on CBD concentration, allowable cannabinoid profiles, and which products qualify may create conflict between patient access advocates and those concerned about psychoactive effects
  • Relationship to broader cannabis legalization: Some opponents may view this as a "foot in the door" toward full cannabis legalization, while others argue it doesn't go far enough toward comprehensive medical cannabis access
  • Regulatory burden on businesses: Small operators may challenge licensing costs, compliance requirements, and ongoing regulatory oversight as economically prohibitive compared to current informal markets

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.